利妥昔单抗联合化疗可提高未治疗的非生发中心型弥漫性大B细胞淋巴瘤患者的生存率。 - Suppr

Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.

作者信息

Saito B, Shiozawa E, Usui T, Nakashima H, Maeda T, Hattori N, Shimozuma J, Adachi D, Yamochi-Onizuka T, Takimoto M, Nakamaki T, Ota H, Tomoyasu S

出版信息

Leukemia. 2007 Dec;21(12):2563-6. doi: 10.1038/sj.leu.2404844. Epub 2007 Jun 28.

DOI:10.1038/sj.leu.2404844

PMID:17597802

Abstract

摘要

相似文献

Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.

Leukemia. 2007 Dec;21(12):2563-6. doi: 10.1038/sj.leu.2404844. Epub 2007 Jun 28.

Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.

J Clin Oncol. 2008 Oct 1;26(28):4587-94. doi: 10.1200/JCO.2007.15.9277. Epub 2008 Jul 28.

Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.

J Clin Oncol. 2011 Feb 20;29(6):690-7. doi: 10.1200/JCO.2010.31.1142. Epub 2010 Dec 28.

Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma.

Cancer Chemother Pharmacol. 2012 May;69(5):1165-72. doi: 10.1007/s00280-011-1814-6. Epub 2012 Jan 4.

Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.

Ann Hematol. 2012 Jun;91(6):837-45. doi: 10.1007/s00277-011-1375-0. Epub 2011 Dec 9.

The role of genotype in 104 cases of diffuse large B-cell lymphoma primary of breast.

Am J Clin Oncol. 2012 Apr;35(2):126-9. doi: 10.1097/COC.0b013e318209aa12.

High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy.

Eur J Haematol. 2012 Jun;88(6):510-7. doi: 10.1111/j.1600-0609.2012.01778.x. Epub 2012 Mar 27.

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.

Cancer. 2011 Mar 1;117(5):964-73. doi: 10.1002/cncr.25582. Epub 2010 Oct 19.

Cancer. 2011 Aug 1;117(15):3530; author reply 3531. doi: 10.1002/cncr.25948. Epub 2011 Feb 1.

Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma.

Haematologica. 2006 May;91(5):715-6.

引用本文的文献

Pediatric T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (THRLBC) in an 8-Year-Old Male Child: A Case Report.

Case Rep Oncol Med. 2025 Feb 22;2025:8869045. doi: 10.1155/crom/8869045. eCollection 2025.

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.

J Exp Clin Cancer Res. 2020 Jul 25;39(1):142. doi: 10.1186/s13046-020-01623-w.

Long Noncoding RNA SNHG12 Indicates the Prognosis and Accelerates Tumorigenesis of Diffuse Large B-Cell Lymphoma Through Sponging microR-195.

Onco Targets Ther. 2020 Jun 12;13:5563-5574. doi: 10.2147/OTT.S249429. eCollection 2020.

Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.

Cancer Med. 2018 May;7(5):1845-1851. doi: 10.1002/cam4.1457. Epub 2018 Apr 6.

Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.

J Hematol Oncol. 2017 Feb 2;10(1):37. doi: 10.1186/s13045-017-0391-5.

[Efficacy of additional two cycles of rituximab administration for patients with diffuse large B-cell lymphoma in first remission].

Zhonghua Xue Ye Xue Za Zhi. 2016 Sep 14;37(9):756-761. doi: 10.3760/cma.j.issn.0253-2727.2016.09.006.

The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.

PLoS One. 2015 May 14;10(5):e0126615. doi: 10.1371/journal.pone.0126615. eCollection 2015.

Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.

Korean J Intern Med. 2014 Nov;29(6):785-92. doi: 10.3904/kjim.2014.29.6.785. Epub 2014 Oct 31.

Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP.

Blood Res. 2014 Sep;49(3):162-9. doi: 10.5045/br.2014.49.3.162. Epub 2014 Sep 25.

Treatment of diffuse large B cell lymphoma.

Korean J Intern Med. 2012 Dec;27(4):369-77. doi: 10.3904/kjim.2012.27.4.369. Epub 2012 Nov 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献